XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities    
Net loss $ (10,947) $ (9,383)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 1,946 1,652
Share-based compensation expense 3,109 9,787
Changes in operating assets and liabilities:    
Accounts receivable 4,069 (6,062)
Income tax receivable (3,823) (6,110)
Deferred cost of goods sold 1,633 (643)
Escrow receivable 75,063 (58)
Prepaid expenses and other current assets 207 1,230
Deferred tax asset (108) 0
Accounts payable (1,679) 542
Accrued expenses 292 (1,874)
Contract liabilities 0 (4,500)
Income tax payable 1,334 0
Deferred tax liability 108 (49,339)
Net cash provided by (used in) operating activities 71,204 (64,758)
Investing activities    
Purchase of property and equipment (3,049) (1,509)
Net cash used in investing activities (3,049) (1,509)
Financing activities    
Share repurchases of common stock and warrants, net 0 (420,000)
Dividends (75,003) 0
Issuance of common stock under stock option plan 7,962 10,426
Net cash used in financing activities (67,041) (409,574)
Effect of foreign exchange rate on cash and cash equivalents 397 (322)
Net change in cash and cash equivalents 1,511 (476,163)
Cash and cash equivalents, beginning of period 237,366 714,594
Cash and cash equivalents, end of period 238,877 238,431
Supplemental Information:    
Accrued purchases of property and equipment $ 202 $ 1,179